Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Halcinonide is a high-potency synthetic corticosteroid used topically to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, including conditions such as eczema and psoriasis. It works primarily by reducing inflammation, itching, redness, swelling, and discomfort in affected skin areas. The mechanism of action involves blocking specific chemicals that cause inflammation and moderating the immune response in the skin. Halcinonide also exhibits vasoconstrictive properties. It is available as a cream or solution (typically 0.1%) for topical application. Halcinonide is considered highly potent among topical steroids and should generally be used for short-term management on small areas of affected skin to minimize systemic absorption and side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on halcinonide.